GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bruker Corp (NAS:BRKR) » Definitions » Ending Cash Position

BRKR (Bruker) Ending Cash Position : $187 Mil (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Bruker Ending Cash Position?

Bruker's Ending Cash Position for the quarter that ended in Dec. 2024 was $187 Mil.

Bruker's quarterly Ending Cash Position declined from Jun. 2024 ($173 Mil) to Sep. 2024 ($152 Mil) but then increased from Sep. 2024 ($152 Mil) to Dec. 2024 ($187 Mil).

Bruker's annual Ending Cash Position declined from Dec. 2022 ($649 Mil) to Dec. 2023 ($492 Mil) and declined from Dec. 2023 ($492 Mil) to Dec. 2024 ($187 Mil).

Bruker Ending Cash Position Historical Data

The historical data trend for Bruker's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bruker Ending Cash Position Chart

Bruker Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 685.50 1,071.70 648.70 491.60 186.70

Bruker Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 491.60 343.30 173.20 151.70 186.70

Bruker Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Bruker's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=491.6+-304.9
=187

Bruker's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=151.7+35
=187

Bruker Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Bruker's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Bruker Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bruker Corp (NAS:BRKR) » Definitions » Ending Cash Position
Comparable Companies
GKOS BIO INSP ITGR IRTC TMDX HAE MASI PRCT SSII ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
BRKR:Mexico BKD:Germany BKD:Germany
Address
40 Manning Road, Billerica, MA, USA, 01821
Website
https://www.bruker.com
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Executives
Richard A Packer director 9 KENDALL DRIVE, WESTBOROUGH MA 01581
Frank H Laukien director, 10 percent owner, officer: CEO, President C/O BRUKER DALTONICS, 40 MANNING ROAD, BILLERICA MA 01821
Bob Rosenthal director 20 NEWBURY ST, BOSTON MA 02116
Hermann Fritz Requardt director C/O BRUKER CORP., 40 MANNING ROAD, BILLERICA MA 01821
Burkhard Prause officer: Pres. & CEO, Bruker EST BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Marc A Kastner director BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Cynthia M Friend director C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Philip Ma director C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Mark Munch officer: Pres. Bruker Nano Inc. BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Juergen Srega officer: Group President Bruker CALID BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Bonnie H Anderson director 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO CA 94080
Martin Gilles Gerard Jean director BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Falko Busse officer: President, BioSpin Group 40 MANNING ROAD, BILLERICA MA 01821
Gerald N Herman officer: Vice President, Corp Contr. 55 EXECUTIVE DRIVE, HUDSON NH 03051
Ingen Chris Van director 395 PAGE MILL RD, MS A3 18, PALO ALTO CA 94306